According to the World Health Organization, breast cancer takes the lives of over 1700 women and men around the world every single day. But survival rates are increasing, thanks to increased awareness and the innovative work of researchers like you, who help develop earlier detection methods and improved treatment strategies.
For this year’s Breast Cancer Awareness Month, we’ve collected some of our recent breast-cancer related webinars, application notes, videos and other resources. Read on and discover how optimized solutions from QIAGEN can accelerate your innovations and help you make a difference faster.
Dr. Sabine Kasimir-Bauer, Associate Professor at the University Hospital of Essen, Germany, discusses the value of multimodality approaches in liquid biopsy and how to achieve a more complete picture of liquid biopsies by analyzing circulating tumor cells, extracellular vesicles and cell-free DNA in parallel.
Dr. Verena Schramm, Associate Director, GeneGlobe, shows how the GeneGlobe Design & Analysis Hub can simplify your experiment planning by connecting biological knowledge on your targets with relevant products and tools. She uses an example breast cancer research planning workflow to demonstrate a variety of GeneGlobe functionalities.
This short video tutorial shows how to use GeneGlobe to explore and gather biological knowledge while building a hypothesis in breast cancer research. We show how to explore pathway information, compile a list of candidate genes and create a custom NGS panel to analyze these genes.
In this slide deck, we showcase breast cancer-relevant application data, collected using our newest digital PCR technology. The QIAcuity dPCR system, combined with our extensive portfolios of dPCR LNA Mutation Assays and dPCR CNV Assays, lets you extensively study individual cancer genes and related pathways with highest precision and sensitivity.View the slides
Learn about a multifaceted approach for identifying differences among tumor subtypes. QIAGEN Ingenuity Variant Analysis and QIAGEN Ingenuity Pathway Analysis enable rapid interpretation and integration of human genome and transcriptome data to generate novel hypotheses about the regulation and effects of change patterns observed in analyzed data.Read the application note
The miRCURY LNA miRNA Probe PCR system offers hydrolysis probe-based miRNA detection to complement our popular SYBR Green-based system. The system provides robust and highly sensitive miRNA profiles for your most demanding applications. Choose from over 30,000 predesigned assays or design your own.Discover miRCURY Probe PCR
The QuantiNova LNA PCR systems offer the broadest coverage with over 2.6 million predesigned human, mouse and rat mRNA/lncRNA assays and a wide selection of focus panels – with the option to customize your own. Available in both SYBR Green or hydrolysis probe versions.Discover QuantiNova LNA PCR
The QIAGEN Cancer Research Community is for dedicated and passionate cancer researchers. We are working to conquer cancer with an emphasis on collaborating together worldwide to share knowledge, methods and data to enable breakthroughs in cancer research.Discover QIAGEN’s Cancer Research Community